144: Issuer Information

Name of Issuer

Cencora, Inc.

SEC File Number

001-16671

Address of Issuer

1 West First Avenue
Conshohocken
PENNSYLVANIA
19428-1800

Phone

610-727-7000

Name of Person for Whose Account the Securities are To Be Sold

Walgreens Boots Alliance Holdings LLC

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common Stock

J.P. Morgan Securities LLC
383 Madison Avenue
New York NY 10179

2700000

531414000

200853998

11/09/2023

NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common Stock

08/25/2016

Shares acquired upon exercise of warrant

The Issuer

22696912

08/25/2016

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

In accordance with the procedures described in the interpretive letters from the staff of the Securities and Exchange Commission to Goldman, Sachs & Co., dated December 20, 1999, and to Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated, dated December 1, 2011, the Shares being sold are subject to variable pre-paid forward sale contracts (the "Contracts") each between Walgreens Boots Alliance Holdings LLC ("Counterparty") and a financial institution. The Contracts will provide for up-front cash payment to Counterparty. At maturity of the Contracts, Counterparty will be obligated to deliver to the relevant financial institution a number of shares as determined by a formula specified in the relevant Contract (or the cash equivalent thereof) and may, under certain circumstances, receive an additional cash payment. Any initial hedging activity in connection with the Contracts will be conducted by or through the broker named in Section 3(b).

Date of Notice

11/09/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Joseph B. Amsbary, Jr.

144: Filer Information

Submission Contact Information